Viewing Study NCT06348121



Ignite Creation Date: 2024-05-06 @ 8:20 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06348121
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-26
First Post: 2024-03-28

Brief Title: Impact of Probiotics on Children With ADHD
Sponsor: Wecare Probiotics Co Ltd
Organization: Wecare Probiotics Co Ltd

Study Overview

Official Title: Effect of WecProB on Clinical Features and Gut Microbiota of Attention Deficit Hyperactivity Disorder in Children
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the efficacy and safety of probiotic product WecProB as food supplements for the treatment of clinical symptoms in children with ADHD in comparison with placebo
Detailed Description: Randomized groups were given a combination of probiotics or placebo in addition to treatment with a consistent dose 12 mgkgd of conventional ADHD medication atomoxetine The total length of the study is 12 weeks and at weeks 0 4 8 and 12 weeks of the trial the clinical symptoms of ADHD will be assessed using a scale Blood and stool samples will be collected at weeks 0 and 12 and psychological tests will be performed Nucleic acid sequencing technology was used to identify bacterial species in feces and high-throughput 16S rRNA sequences were quickly obtained by sequencing and fecal metabolites were analyzed

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None